Association of hypoalbuminemia with short-term and long-term mortality in patients undergoing continuous renal replacement therapy

Background : : Hypoalbuminemia reflects several pathological conditions, including nutritional deficiencies and chronic inflammation. However, its relationship with short-term and long-term mortality in patients undergoing continuous renal replacement therapy (CRRT) remains unclear. The present stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Jong Joo Moon (Author), Yaerim Kim (Author), Dong Ki Kim (Author), Kwon Wook Joo (Author), Yon Su Kim (Author), Seung Seok Han (Author)
Format: Book
Published: The Korean Society of Nephrology, 2020-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_b4924d3f19f14168a9ca09a7b14f384b
042 |a dc 
100 1 0 |a Jong Joo Moon  |e author 
700 1 0 |a Yaerim Kim  |e author 
700 1 0 |a Dong Ki Kim  |e author 
700 1 0 |a Kwon Wook Joo  |e author 
700 1 0 |a Yon Su Kim  |e author 
700 1 0 |a Seung Seok Han  |e author 
245 0 0 |a Association of hypoalbuminemia with short-term and long-term mortality in patients undergoing continuous renal replacement therapy 
260 |b The Korean Society of Nephrology,   |c 2020-03-01T00:00:00Z. 
500 |a 2211-9132 
500 |a 10.23876/j.krcp.19.088 
520 |a Background : : Hypoalbuminemia reflects several pathological conditions, including nutritional deficiencies and chronic inflammation. However, its relationship with short-term and long-term mortality in patients undergoing continuous renal replacement therapy (CRRT) remains unclear. The present study aimed to assess the effect of hypoalbuminemia on mortality in a large cohort of patients undergoing CRRT. Methods : : The study retrospectively reviewed 1,581 patients who underwent CRRT for the treatment of acute kidney injury from 2010 to 2016. The patients were categorized by tertiles of serum albumin levels at CRRT initiation. The odds ratios and hazard ratios for the risk of all-cause mortality were calculated before and after adjustment for multiple covariates. Results : : The mean albumin level was 2.7 ± 0.6 g/dL at CRRT initiation. During a median follow-up period of 14 days (maximum, 4 years), 1,040 patients (65.8%) died. The risk of overall mortality was higher in the first tertile group than in the third tertile group (hazard ratio, 1.9 [1.63-2.21]). When the mortality rate was stratified by timeframe, the risk was steadily higher in the first tertile group than in the third tertile group (odds ratios: 3.0 [2.34-3.87] for 2-week mortality, 2.7 [2.12-3.52] for 1-month mortality, 2.7 [2.08-3.53] for 6-month mortality, and 2.8 [2.11-3.62] for 1-year mortality). Additionally, the rates of intensive care unit mortality and in-hospital mortality were higher in the first tertile group than in the third tertile group. Conclusion : : The initial hypoalbuminemia was independently associated with short-term and long-term mortality in patients undergoing CRRT. Thus, the serum albumin level should be monitored during CRRT. 
546 |a EN 
546 |a KO 
690 |a acute kidney injury 
690 |a continuous renal replacement therapy 
690 |a hypoalbuminemia 
690 |a mortality 
690 |a Internal medicine 
690 |a RC31-1245 
690 |a Specialties of internal medicine 
690 |a RC581-951 
655 7 |a article  |2 local 
786 0 |n Kidney Research and Clinical Practice, Vol 39, Iss 1, Pp 47-53 (2020) 
787 0 |n https://doi.org/10.23876/j.krcp.19.088 
787 0 |n https://doaj.org/toc/2211-9132 
856 4 1 |u https://doaj.org/article/b4924d3f19f14168a9ca09a7b14f384b  |z Connect to this object online.